Latest filing published 03 Feb 2016 for ARIAD PHARMACEUTICALS INC. Read the official filing
No signal scores available.
Edward M. Fitzgerald is a declared insider of Ariad Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 1 February 2016, with 2 filings.
Every open-market trade on record is a sale: 1 sale. The amount is not disclosed for 1 filing. Besides market trades, the filings include 1 option exercise.
Most recently, on 3 February 2016, the filings show an option exercise in Ariad Pharmaceuticals Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations